Fibrin but not adsorbed fibrinogen supports fibronectin assembly by spread platelets -: Effects of the interaction of αIIbβ3 with the C terminus of the fibrinogen γ-chain

被引:28
作者
Cho, J
Degen, JL
Coller, BS
Mosher, DF
机构
[1] Univ Wisconsin, Dept Med, Med Sci Ctr 4285, Sch Med, Madison, WI 53706 USA
[2] Univ Wisconsin, Sch Med, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA
[3] Univ Cincinnati, Coll Med, Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA
[4] Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10021 USA
关键词
D O I
10.1074/jbc.M506289200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the assembly of soluble fibronectin by lysophosphatidic acid- activated platelets adherent to fibrinogen or fibrin. More fibronectin was assembled by activated platelets spread on fibrin matrices than by platelets spread on adsorbed fibrinogen. The difference between platelets adherent to fibrinogen and fibrin occurred under both static and flow conditions. Similar differences were seen in binding of the 70- kDa N- terminal fragment of fibronectin that recognizes fibronectin assembly sites on adherent cells. Antibody and peptide blocking studies demonstrated that alpha IIb beta 3 integrin mediates platelet adhesion to fibrinogen, whereas both alpha v beta 3 and alpha IIb beta 3 mediate platelet adhesion to fibrin. The hypothesis that engagement of the C- terminal QAGDV sequence of the fibrinogen gamma-chain by alpha IIb beta 3 inhibits the ability of the platelet to assemble fibronectin was tested by several experiments. Activated platelets adherent to adsorbed mutant fibrinogen lacking the QAGDV sequence ( gamma Delta 5FG) were assembly- competent, as were platelets adherent to adsorbed normal fibrinogen that had been pretreated with the 7E9 antibody to the C terminus of the gamma- chain. Moreover, adsorbed normal fibrinogen but not gamma Delta 5FG suppressed the ability of co- adsorbed fibronectin to direct assembly of soluble fibronectin by spread platelets. The suppressive effect was lost when a surface of co- adsorbed fibronectin and fibrinogen was pretreated with 7E9. These results support a model in which the engagement of alpha IIb beta 3 by the C- terminal sequence of the fibrinogen gamma-chain initiates signals that suppress subsequent fibronectin assembly by spread platelets. This interaction is less dominant when platelets adhere to fibrin, resulting in enhanced fibronectin assembly.
引用
收藏
页码:35490 / 35498
页数:9
相关论文
共 66 条
[1]   Endothelial cell VE-cadherin functions as a receptor for the β15-42 sequence of fibrin [J].
Bach, TL ;
Barsigian, C ;
Yaen, CH ;
Martinez, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (46) :30719-30728
[2]   Assembly of exogenous fibronectin by fibronectin-null cells is dependent on the adhesive substrate [J].
Bae, E ;
Sakai, T ;
Mosher, DF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (34) :35749-35759
[3]  
BARRY ELR, 1988, J BIOL CHEM, V263, P10464
[4]  
BARRY ELR, 1989, J BIOL CHEM, V264, P4179
[5]   Transglutaminase-mediated oligomerization of the fibrin(ogen) αC domains promotes integrin-dependent cell adhesion and signaling [J].
Belkin, AM ;
Tsurupa, G ;
Zemskov, E ;
Veklich, Y ;
Weisel, JW ;
Medved, L .
BLOOD, 2005, 105 (09) :3561-3568
[6]  
BITTORF SV, 1993, J BIOL CHEM, V268, P24838
[7]   Improvements to parallel plate flow chambers to reduce reagent and cellular requirements [J].
Brown D.C. ;
Larson R.S. .
BMC Immunology, 2 (1)
[8]   ENDOTHELIAL-CELL SPREADING ON FIBRIN REQUIRES FIBRINOPEPTIDE-B CLEAVAGE AND AMINO-ACID-RESIDUES 15-42 OF THE BETA CHAIN [J].
BUNCE, LA ;
SPORN, LA ;
FRANCIS, CW .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (03) :842-850
[9]   IDENTIFICATION OF POLYPEPTIDE CHAINS INVOLVED IN CROSS-LINKING OF FIBRIN [J].
CHEN, R ;
DOOLITTLE, RF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1969, 63 (02) :420-+
[10]   RECOGNITION OF DISTINCT ADHESIVE SITES ON FIBRINOGEN BY RELATED INTEGRINS ON PLATELETS AND ENDOTHELIAL-CELLS [J].
CHERESH, DA ;
BERLINER, SA ;
VICENTE, V ;
RUGGERI, ZM .
CELL, 1989, 58 (05) :945-953